This possibility is consistent with the data reported by Luo et al. [16], who demonstrated the antitumoral effects of TGF-β activity, and by Novitskiy et al. [25], who reported that the loss of the TGF-β receptor (and thus the activity of the cytokine) promoted breast cancer progression. Here, TGFB1 is linked to breast carcinoma.